Novel targeted therapies: A challenge for drug development

Chandra P. Belani

doi:10.3816/CLC.2003.s.008

Novel targeted therapies: A challenge for drug development

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	S4
Journal	Clinical Lung Cancer
Volume	5
Issue number	SUPPL. 1
DOIs	https://doi.org/10.3816/CLC.2003.s.008
State	Published - Sep 2003

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3816/CLC.2003.s.008

Cite this

@article{5951099a72e344f197b6e954d3f17956,

title = "Novel targeted therapies: A challenge for drug development",

author = "Belani, {Chandra P.}",

year = "2003",

month = sep,

doi = "10.3816/CLC.2003.s.008",

language = "English (US)",

volume = "5",

pages = "S4",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Novel targeted therapies

T2 - A challenge for drug development

AU - Belani, Chandra P.

PY - 2003/9

Y1 - 2003/9

UR - http://www.scopus.com/inward/record.url?scp=0142029047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142029047&partnerID=8YFLogxK

U2 - 10.3816/CLC.2003.s.008

DO - 10.3816/CLC.2003.s.008

M3 - Editorial

AN - SCOPUS:0142029047

SN - 1525-7304

VL - 5

SP - S4

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - SUPPL. 1

ER -

Novel targeted therapies: A challenge for drug development

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this